Actuate Therapeutics (ACTU) Shares Issued (2023 - 2025)
Actuate Therapeutics (ACTU) posted quarterly Shares Issued of $1.8 million for Q4 2025, up 135.99% year-over-year from $780539.0 in Q4 2024, and up 2.08% quarter-over-quarter from $1.8 million in Q3 2025.
Actuate Therapeutics (ACTU) Shares Issued (2023 - 2025) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Shares Issued for 3 consecutive years, with $1.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Issued rose 135.99% year-over-year to $1.8 million; the TTM figure through Dec 2025 stood at $1.8 million (up 135.99% YoY), while the FY2025 annual figure was $1.8 million, up 135.99% from the prior year.
- Shares Issued advanced to $1.8 million in Q4 2025 per ACTU's latest filing, from $1.8 million in the prior quarter.
- Across five years, Shares Issued topped out at $1.8 million in Q4 2025 and bottomed at $265566.0 in Q4 2023.
- Historically, Shares Issued has averaged $1.1 million across 3 years, with a median of $820539.0 in 2024.
- On a YoY basis, Shares Issued climbed as much as 351.12% in 2025 and fell as far as 135.99% in 2025.
- Actuate Therapeutics' Shares Issued stood at $265566.0 in 2023, then jumped by 193.92% to $780539.0 in 2024, then soared by 135.99% to $1.8 million in 2025.
- Business Quant data shows ACTU's Shares Issued at $1.8 million in Q4 2025, $1.8 million in Q3 2025, and $1.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Actuate Therapeutics | 30.08 Mn | 30.08 Mn | - | 2.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.84 Mn |
| Dec 31, 2025 | 1.84 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Mar 31, 2025 | 860,539.00 |
| Mar 31, 2025 | 860,539.00 |
| Dec 31, 2024 | 780,539.00 |
| Dec 31, 2024 | 780,539.00 |
| Sep 30, 2024 | 763,317.00 |
| Sep 30, 2024 | 763,317.00 |
| Jun 30, 2024 | 393,346.00 |
| Jun 30, 2024 | 393,346.00 |
| Dec 31, 2023 | 265,566.00 |
| Dec 31, 2023 | 265,566.00 |